If things works out well for IMU, surely Biogen has the money to buyout or merge with Imu (much later down the track). I was rebutting a comment made on lowball offer. After secure funds for the trials for this year. Imu is not in a position to attract any lowball offers. Usually if a lowball offer is taking shape any where one will smell one of the two things 1 financial distress and 2 company's core business/strategy on shaky grounds. Imu doesn't fit the bill.
Any way taking of M&A's i would prefer the other Gen (Amgen). Purely becoz we have a history and company is much bigger than Biogen.
Dyor
spidey
If things works out well for IMU, surely Biogen has the money to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |